Reuters exclusively reported that Private equity firm Carlyle Group Inc (CG.O) has entered into exclusive negotiations to acquire a majority stake in two medical device businesses of Medtronic Plc (MDT.N) at a valuation of more than $7 billion. 

Market Impact

Medtronic is seeking to streamline its portfolio and focus on its higher-growth assets, such as its heart and diabetes devices, by divesting the two units which generated approximately $2.2 billion in revenue in the 2022 fiscal year according to the company. 

Article Tags

Topics of Interest: DealsTechnology

Type: Reuters Best

Sectors: Business & FinancePharmaceuticals & HealthcareTechnology

Regions: Americas

Countries: US

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

Source link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *